| Abstract | The data obtained on 68 patients suffering from cardiac arrhythmia treated with bonnecor or ethacizine demonstrate that bonnecor corrects ventricular extrasystole including high-grade arrhythmia in 80.4% of the patients while ethacizine in 84.6%. Acute tests with the drugs can effectively prognosticate the outcomes of bonnecor or ethacizine long-term treatment. The drugs eliminate delta-wave and stimulation-induced arrhythmias in 90% and 44-56% of patients with WPW syndrome, respectively. Bonnecor is less effective in nodal tachycardia. Both the drugs noticeably suppress conductivity. |
| Authors | I P Tatarchenko, N N Ermolaeva, V E Oleĭnikov, A V Perevarin, F K Rakhmatullov |
| Journal | Klinicheskaia meditsina
(Klin Med (Mosk))
Vol. 69
Issue 8
Pg. 60-2
(Aug 1991)
ISSN: 0023-2149 USSR |
| Vernacular Title | Sravnitel'noe issledovanie éffektivnosti bonnekora i étatsizina pri nekotorykh narusheniiakh serdechnogo ritma. |
| PMID | 1724273
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
|
| Chemical References |
- Anti-Arrhythmia Agents
- Dibenzazepines
- Phenothiazines
- ethacizine
- tiracizine
|
| Topics |
- Adolescent
- Adult
- Aged
- Anti-Arrhythmia Agents
(therapeutic use)
- Atrial Fibrillation
(drug therapy)
- Cardiac Complexes, Premature
(drug therapy)
- Dibenzazepines
(therapeutic use)
- Humans
- Middle Aged
- Phenothiazines
(therapeutic use)
- Tachycardia, Supraventricular
(drug therapy)
|
